Page 269 - FINAL PROGRAMME 2017

P-516 Effects of vitri cation on functional morophology and viability of ovarian tissue
I.V. Malinova1, V.V. Yuzhakov2, M.V. Kiseleva1, E.V. Komarova3, L.N. Bandurko2, L.E. Sevankaeva2, A.D. Kaprin3
1Division of Innovative Medical Technology, A. Tsyb Medical Radiological Research Centre, branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
2Laboratory of Radiologic Pathomorphology, A. Tsyb Medical Radiological Research Centre, branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
3National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Obninsk, Russian Federation.
P-517 The majority of women who bank their oocytes conceives naturally
E. Balkenende1, T. Dahhan1, F. Van Der Veen1, S. Repping1, M. Goddijn1
1Academic Medical Center, Center for Reproductive Medicine, Amsterdam, The Netherlands
P-518 Gender and educational disparities underlying elective egg freezing: results from the rst major qualitative study of oocyte cryopreservation in the United States and Israel
M. Inhorn1, D. Birenbaum-Carmeli2, L. Westphal3, J. Doyle4, N. Gleicher5, M. Dirnfeld6, D. Seidman7, A. Kahane8, D. Meirow9, P. Patrizio10
1Yale University, Anthropology & International Affairs, New Haven- Connecticut, U.S.A. 2University of Haifa, School of Nursing, Haifa, Israel
3Stanford University, Obstetrics and Gynecology, Stanford- California, U.S.A.
4Shady Grove Fertility, Reproductive Science Center, Rockville- MD, U.S.A.
5Center for Human Reproduction, Fertility and IVF Center, New York- NY, U.S.A. 6Carmel Medical Center, IVF Unit, Haifa, Israel
7Tel Aviv University, Sheba Medical Center, Ramat Gan, Israel
8Assuta Medical Center, IVF Unit, Rishon Lezion, Israel
9Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
10Yale University, Obstetrics and Gynecology, New Haven- CT, U.S.A.
P-519 Comparison of ovarian reserve and ovarian response to hyperstimulation in women undergoing oocyte vitri cation according to the type of malignancy
T. Lefebvre1,2, M. Jegu1, S. Mirallié1, F. Leperlier1, P. Barrière1,2,3, T. Fréour1,2,3 1Hospital University of Nantes, Department of Reproductive Medicine, Nantes, France 2University of Nantes, Faculty of Medicine, Nantes, France
3INSERM UMR 1064, INSERM, Nantes, France
P-521 Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients
D.Y. Lee1, C.W. Mok1, D. Choi1
1Samsung Medical Center, Obstetrics and Gynecology, Seoul, Korea- South
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 269
POSTERS